Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Marriott International Inc (MAR) Price & Performance

Definium Therapeutics Inc. Common SharesTrade
Marriott International Inc Trade

Price performance (Past 24H)

Key statistics

Definium Therapeutics Inc. Common Shares vs Marriott International Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.73 (market cap $4.59B), while Marriott International Inc trades at $363.94 (market cap $94.16B). The key difference: Marriott International Inc is far larger — about 20.5× Definium Therapeutics Inc. Common Shares's market cap, and Marriott International Inc pays a 0.81% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Marriott International Inc for 164 Days on average.

DFTXMAR
Market Cap
$4.59B$94.16B
Volume
2,103,937996,176
Sector
HealthConsumer Cyclical
52-Week High
$48.45$402.54
52-Week Low
$10.68$259.04
Typical Hold Time
0 Days164 Days
Enterprise Value
$3.55B$111.47B
Dividend Yield
—0.81%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Definium Therapeutics Inc. Common Shares

No Aura AI signal available yet.

Marriott International Inc

Marriott International (MAR) trades at $356.5, down 1.32% on the day, with a bullish technical signal supported by moving averages. Revenue grew to $26.19B in 2025, with a net income margin of 9.62%. Recent earnings beat expectations in Q1 and Q2 2026, while Q3 results are pending. The company maintains strong cash flow from operations at $3.21B and announced a dividend of $0.73 per share payable in September 2026.

The outlook is positive with a consensus price target of $386.71, implying upside. Risks include high debt levels and competitive pressures. Analyst sentiment is mixed with 44% buy ratings, but institutional interest remains strong, supporting a cautiously optimistic view for long-term investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DFTX
100% Buy0% Sell
Avg holding period · 0 Days
MAR
86% Buy14% Sell
Avg holding period · 164 Days

Top news

Latest headlines on both assets

About Definium Therapeutics Inc. Common Shares

Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.

Read more on DFTX →

About Marriott International Inc

Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.

Read more on MAR →